ev3 has initiated a voluntary removal of two lots of Axium Detachable Coil System for product mislabeling as the lots were swapped in production.
Source facts
Action
Micro Therapeutics Inc, dba ev3 Neurovascular performed product recovery according to the following outline.
a) Quality Assurance Department (QAD) was used to provide details of product distribution for the affected lots.
b) Based on the Health Hazard Assessment, the risk was considered undesirable.
c) The affected product was part of a limited market release for Physician Preference Testing. As the product was within control of ev3 employees, no public notification was performed.
d) Quality Systems contacted the sales representatives identifying the part number, lot number and number of units sent, and a request to segregate and return the affected product was initiated.
e) Product returned to ev3 Neurovascular was held in Restricted Stock pending complete device accountability and disposition.
f) The ev3 Neurovascular Quality Assurance department scrapped the affected product.
g) The ev3 Neurovascular Regulatory Affairs department was responsible for assuring documentation and appropriate notification to regulatory bodies as required.
Initiated
2010-03-01
Root cause
Employee error
Terminated
2012-01-31
Distribution
Worldwide Distribution - USA (nationwide) and the countries of the UK, and France.
Recall number
Z-0874-2012
Recall status
Terminated
CDRH record ID
91588
FDA classified
2012-01-26
Recall event number
55696
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.